See All Slides - tctmd.com

Slides

Presentation TCT 2012

History of SCAI and CCI

Presenter: Frank Hildner

October 23, 2012

Presentation TCT 2012

Yes: The Quantitative Threshold Should Be Lowered!

Presenter: Maurice Sarano

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Presenter: Mehdi Shishehbor

October 23, 2012

Presentation TCT 2012

TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial

Presenter: Eberhard Grube

October 23, 2012

Presentation TCT 2012

When Should MVD be Managed Medically?

Presenter: William Boden

October 23, 2012

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Presenter: Hendrik Treede

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Presenter: Usman Baber

October 23, 2012

Advertisement

Slides

History of SCAI and CCI

Yes: The Quantitative Threshold Should Be Lowered!

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial

When Should MVD be Managed Medically?

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Autologous Cardiac Stem Cells in VAD Patients

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Pathogenesis of Vulnerable Plaque 2012: What's New?

TCT-72. Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV Trials

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content